Legal Opinion
Lacey v. Novo Nordisk A/S
District Court, M.D. Louisiana
Decided May 23, 2024No. 3:24-cv-00367Unknown
1Opinion
UNITED STATES DISTRICT COURT MIDDLE DISTRICT OF LOUISIANA ERICA LACEY CIVIL ACTION NO. VERSUS 24-367-BAJ-EWD NOVO NORDISK A/S, et al. NOTICE AND ORDER On May 9, 2024, Erica Lacey (“Plaintiff”) filed a Complaint and Demand for Jury Trial (“Complaint”) in this Court against the manufacturers, distributors, and marketers of Ozempic, an injectable prescription medication used to control blood sugar.1 Named as defendants in the litigation are Novo Nordisk A/S; Novo Nordisk North America Operations A/S; Novo Nordisk US Holdings Inc.; Novo Nordisk US Commercial Holdings Inc.; Novo Nordisk Inc.; Novo…
2Cases cited7 opinions
- Arbaugh v. Y & H Corp.Supreme Court of the United States · 2006
- Gibbs v. BuckSupreme Court of the United States · 1939
- Harvey v. Grey Wolf Drilling Co.Court of Appeals for the Fifth Circuit · 2008
- MidCap Media Finance, L.L.C. v. Pathway Data, IncoCourt of Appeals for the Fifth Circuit · 2019
- McDonal Ex Rel. McDonal v. Abbott LaboratoriesCourt of Appeals for the Fifth Circuit · 2005
2 more not listed; retrieve them via the Exa API.